Cancer cocktail trial halted: immunotherapy plus radiation shows promise but stops short
NCT ID NCT04785287
First seen Nov 21, 2025 · Last updated Apr 28, 2026 · Updated 14 times
Summary
This early-stage trial tested a combination of two immunotherapy drugs (BMS-986218 and nivolumab) plus precise, high-dose radiation in 13 people with advanced solid tumors that had spread. The goal was to see if this mix could help the immune system attack cancer more effectively and shrink tumors. The study was terminated early, so final results are limited, but it aimed to control disease rather than cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IIIB LUNG CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.